Lighthouse Pharmaceuticals Announces Progression of LHP588 Clinical Development Program in Alzheimer's Disease
- Pre-IND meeting related to Phase 2b SPRING trial completed with US FDA - World-class clinical advisory board to support clinical development ...
Source: businessinsider.com